Peng-Jun Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peng-Jun Lu has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Walter W. Williams
14 shared publicationsDavid Yankey
12 shared publicationsAlissa O’halloran
Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, Georgia
7 shared publicationsHelen Ding
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
7 shared publicationsJames A. Singleton
Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC
7 shared publicationsAnup Srivastav
Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; Eagle Health Analytics, LLC
6 shared publications
Latest Publications
- 4 November 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 70 (3) , 108180
Human Papillomavirus Vaccination Coverage Among Adults Aged 27–45 Years in the U.S., 3 Years After the Recommendation for Shared Clinical Decision Making
- 4 November 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 70 (3) , 108180
Human Papillomavirus Vaccination Coverage Among Adults Aged 27–45 Years in the U.S., 3 Years After the Recommendation for Shared Clinical Decision Making
- Top Cited Papers
Prevalence of influenza-specific vaccination hesitancy among adults in the United States, 2018
- 17 February 2023
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 72 (7) , 190-198
COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).
- 17 February 2023
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 72 (7) , 190-198
COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).
- Open Access
- 1 January 2023
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 29 (1) , 133-140
COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
COVID-19 Booster Dose Vaccination Coverage, USA
- 1 January 2023
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 29 (1) , 133-140
Open AccessCOVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
COVID-19 Booster Dose Vaccination Coverage, USA
- Open Access
- 22 June 2022
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 150 (1)
Human Papillomavirus Vaccination Trends Among Adolescents: 2015 to 2020
OBJECTIVE: To assess trends in recent human papillomavirus (HPV) vaccination initiation and factors associated with vaccination among adolescents. METHODS: The 2015 to 2020 National Immunization Survey–Teen data were used to assess vaccination trends. Multivariable logistic regression analysis were conducted to assess factors associated with vaccination. RESULTS: Overall, HPV vaccination coverage (≥1 dose) among adolescents significantly increased from 56.1% in 2015 to 75.4% in 2020. There were larger increases in coverage among males (4.7 percentage points annually) than females (2.7 percentage points annually) and coverage differences between males and females decreased in 2015 through 2020. Coverage in 2020 was 75.4% for adolescents aged 13 to 17 years; 73.7% for males and 76.8% for females (P < .05); 80.7% for those with a provider recommendation and 51.7% for those without (P < .05); and 80.3% for those with a well child visit at age 11 to 12 years, and 64.8% for those without (P < .05). Multivariable logistic regression results showed that main characteristics independently associated with a higher likelihood of vaccination included: a provider recommendation, age 16 to 17 years, non-Hispanic Black, Hispanic, or American Indian or Alaskan Native, Medicaid insurance, ≥2 provider contacts in the past 12 months, a well–child visit at age 11 to 12 years and having 1 or 2 vaccine providers (P < .05). CONCLUSIONS: Overall, HPV vaccination coverage among adolescents increased during 2015 to 2020. Coverage increased faster among males than females and differences by sex narrowed during this time. Receiving a provider recommendation vaccination was important to increase vaccination coverage.
- 22 June 2022
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 150 (1)
Open AccessHuman Papillomavirus Vaccination Trends Among Adolescents: 2015 to 2020
OBJECTIVE: To assess trends in recent human papillomavirus (HPV) vaccination initiation and factors associated with vaccination among adolescents. METHODS: The 2015 to 2020 National Immunization Survey–Teen data were used to assess vaccination trends. Multivariable logistic regression analysis were conducted to assess factors associated with vaccination. RESULTS: Overall, HPV vaccination coverage (≥1 dose) among adolescents significantly increased from 56.1% in 2015 to 75.4% in 2020. There were larger increases in coverage among males (4.7 percentage points annually) than females (2.7 percentage points annually) and coverage differences between males and females decreased in 2015 through 2020. Coverage in 2020 was 75.4% for adolescents aged 13 to 17 years; 73.7% for males and 76.8% for females (P < .05); 80.7% for those with a provider recommendation and 51.7% for those without (P < .05); and 80.3% for those with a well child visit at age 11 to 12 years, and 64.8% for those without (P < .05). Multivariable logistic regression results showed that main characteristics independently associated with a higher likelihood of vaccination included: a provider recommendation, age 16 to 17 years, non-Hispanic Black, Hispanic, or American Indian or Alaskan Native, Medicaid insurance, ≥2 provider contacts in the past 12 months, a well–child visit at age 11 to 12 years and having 1 or 2 vaccine providers (P < .05). CONCLUSIONS: Overall, HPV vaccination coverage among adolescents increased during 2015 to 2020. Coverage increased faster among males than females and differences by sex narrowed during this time. Receiving a provider recommendation vaccination was important to increase vaccination coverage.
- 1 October 2021
- Published by Elsevier in Journal of Adolescent Health
- Vol. 69 (4) , 597-603
National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States
- 1 October 2021
- Published by Elsevier in Journal of Adolescent Health
- Vol. 69 (4) , 597-603
National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States
- Top Cited PapersOpen Access
- 14 May 2021
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report
- Vol. 70 (3) , 1-26
Surveillance of Vaccination Coverage Among Adult Populations —United States, 2018
This report describes findings from the National Health Interview Survey on recommended vaccines among adults in the United States.
- 14 May 2021
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report
- Vol. 70 (3) , 1-26
Top Cited PapersOpen AccessSurveillance of Vaccination Coverage Among Adult Populations —United States, 2018
This report describes findings from the National Health Interview Survey on recommended vaccines among adults in the United States.
- 1 March 2019
- Published by Elsevier in The Journal of Pediatrics
- Vol. 206, 33-41.e1
Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years—United States
- 1 March 2019
- Published by Elsevier in The Journal of Pediatrics
- Vol. 206, 33-41.e1
Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years—United States